期刊文献+

帕金森病伴痴呆的流行病学及危险因素 被引量:10

原文传递
导出
摘要 帕金森病(PD)是一种中老年人常见的中枢神经系统变性疾病,认知功能障碍和痴呆在PD患者中发生率很高,伴痴呆的帕金森病(PDD)会严重影响患者的生活质量,并且会给照料者带来很大的工作及生活、心理负担,现将PDD的流行病学、发病机制、诊断标准及发病可能的危险因素综述如下。
出处 《江苏医药》 CAS 北大核心 2013年第6期710-712,共3页 Jiangsu Medical Journal
  • 相关文献

参考文献19

  • 1Cummings JL. Intellectual impairment in Parklnson's disease:clinical,pathologic, and biochemical correlates[J]. J Geriatr Psychiatry Neurol, 1988,1(1) : 24-36.
  • 2乔晋,屈秋民,郭峰,杨剑波,韩建峰,罗国刚,张辉,武成斌.55岁以上自然人群中帕金森病患者认知功能障碍的临床研究[J].西安交通大学学报(医学版),2004,25(1):100-102. 被引量:21
  • 3Martin WE, Loewenson RB, Resch JA, et al. Parkinson's disease: clinical analysis of 100 patients[J]. Neurology, 1973, 23(8) : 783-790.
  • 4Aarsland D, Andersen K, Larsen JP, et al. Risk of dementia in Parkinson's disease: a community-based, prospective study [J]. Neurology, 2001,56 (6) : 730-736.
  • 5de Lau LM, Schipper CM, Hofman A, et al. Prognosis of Parkinson disease: risk of dementia and mortality., the Rotterdam Study[J]. Arch Neurol,2005,62(8)..1265-1269.
  • 6Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom[J]. Mov Disord,2004,19(9) : 1043-1049.
  • 7Marder K, Tang MX, Cote L, et al. The frequency and associated risk factors for dementia in patients with Parkinson's disease[J]. Arch Neurol, 1995,52 (7) : 695-701.
  • 8Hely MA, Morris JG, Reid WG, et al. Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years[J]. Mov Disord,2005,20(2) : 190-199.
  • 9Reid WG, Hely MA,Morris JG, et al. A longitudinal study of Parkinson's disease: clinical and neuropsychological correlates of dementia[J]. J Clin Neurosci, 1996,3(4) : 327-333.
  • 10Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years[J]. Mov Disord,2008,23(6) :837-844.

二级参考文献1

共引文献20

同被引文献102

  • 1冯建军,李雅丽,侯辰,李立博,张巧俊.银杏叶提取物对帕金森病模型大鼠多巴胺神经元的保护作用[J].西安交通大学学报(医学版),2011,32(6):783-786. 被引量:12
  • 2蒋雨平,王坚,丁正同,邬剑军,陈嬿.原发性帕金森病的诊断标准(2005年)[J].中国临床神经科学,2006,14(1):40-40. 被引量:155
  • 3Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impair- ment: clinical characterization and outcome [J]. Arch Neurol, 1999, 56(3): 303-308.
  • 4Lewis SJ, Slabosz A, Robbins TW, et al. Dopaminergic basis for def- icits in working memory but not attentional set-shifting in Parkin- son's disease [J]. Neuropsychologia, 2005, 43(6): 823-832.
  • 5Tervo S, K.ivipelto M, Hanninen T, et al. Incidence and risk factors for mild cognitive impairment: a population-based three-year fol- low-up study of cognitively healthy elderly subjects [J]. Dement (3criatr Cogn Disord, 2004, 17(3): 196-203.
  • 6史玉全,周孝达.实用神经病学[M].第4版.上海:上海科学技术出版社,2006:627-635.
  • 7Daniel P. Perl,C. Warren Olanow.The Neuropathology of Manganese-Induced Parkinsonism[J].Journal of Neuropathology and Experimental Neurology.2007(8)
  • 8Jay M. Gorell,Edward L. Peterson,Benjamin A. Rybicki,Christine Cole Johnson.Multiple risk factors for Parkinson’s disease[J].Journal of the Neurological Sciences.2003(2)
  • 9全国锥体外系疾病讨论会.帕金森病及帕金森综合症的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):256.
  • 10Schneider JS, Gollomp SM, Sendek S, et al. A randomized, controlled, delayed start trial of GM1 ganglioside in treating Parkinson's disease patients [ J ]. Neurol Sci, 2013,324 ( 1 - 2) : 140- 148.

引证文献10

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部